Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16197441 [patent_doc_number] => 10722578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Methods and compositions for treating neuroblastoma [patent_app_type] => utility [patent_app_number] => 14/607573 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 69 [patent_no_of_words] => 25653 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607573 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/607573
Methods and compositions for treating neuroblastoma Jan 27, 2015 Issued
Array ( [id] => 10312574 [patent_doc_number] => 20150197576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Identification of Tumor-Associated Antigens for Diagnosis and Therapy' [patent_app_type] => utility [patent_app_number] => 14/606729 [patent_app_country] => US [patent_app_date] => 2015-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 23458 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14606729 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/606729
Identification of tumor-associated antigens for diagnosis and therapy Jan 26, 2015 Issued
Array ( [id] => 10327072 [patent_doc_number] => 20150212077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'BIOMARKER TFF1 FOR PREDICTING EFFECT OF C-MET INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/604361 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23328 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604361 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/604361
Biomarker TFF1 for predicting effect of C-MET inhibitor Jan 22, 2015 Issued
Array ( [id] => 10233249 [patent_doc_number] => 20150118243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma' [patent_app_type] => utility [patent_app_number] => 14/597786 [patent_app_country] => US [patent_app_date] => 2015-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18860 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14597786 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/597786
Methods and compositions for identifying, diagnosing, and treating neuroblastoma Jan 14, 2015 Issued
Array ( [id] => 11290475 [patent_doc_number] => 20160340407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF MELANOMA USING PD-L1 ISOFORMS' [patent_app_type] => utility [patent_app_number] => 15/110808 [patent_app_country] => US [patent_app_date] => 2015-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 64303 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110808 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/110808
COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF MELANOMA USING PD-L1 ISOFORMS Jan 13, 2015 Abandoned
Array ( [id] => 10408091 [patent_doc_number] => 20150293101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'TUMOR CELL-DERIVED MICROVESICLES' [patent_app_type] => utility [patent_app_number] => 14/595148 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14619 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14595148 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/595148
Tumor cell-derived microvesicles Jan 11, 2015 Issued
Array ( [id] => 11562881 [patent_doc_number] => 09625461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Method of detecting cancer using delta-catenin' [patent_app_type] => utility [patent_app_number] => 14/592499 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10230 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592499 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/592499
Method of detecting cancer using delta-catenin Jan 7, 2015 Issued
Array ( [id] => 11798622 [patent_doc_number] => 09539340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Bladder cancer specific ligand peptides' [patent_app_type] => utility [patent_app_number] => 14/589680 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 23403 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589680 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/589680
Bladder cancer specific ligand peptides Jan 4, 2015 Issued
Array ( [id] => 13117943 [patent_doc_number] => 10077316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-18 [patent_title] => Esophageal cancer marker and use thereof [patent_app_type] => utility [patent_app_number] => 15/108251 [patent_app_country] => US [patent_app_date] => 2014-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 48123 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108251 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/108251
Esophageal cancer marker and use thereof Dec 24, 2014 Issued
Array ( [id] => 11129623 [patent_doc_number] => 20160326597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 15/109464 [patent_app_country] => US [patent_app_date] => 2014-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 25597 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109464 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/109464
DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY Dec 22, 2014 Abandoned
Array ( [id] => 10346216 [patent_doc_number] => 20150231221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING PROGASTRIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/579220 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11572 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579220 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/579220
Immunogenic compositions comprising progastrin and uses thereof Dec 21, 2014 Issued
Array ( [id] => 12029562 [patent_doc_number] => 20170319661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers' [patent_app_type] => utility [patent_app_number] => 15/531128 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12595 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531128 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/531128
Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers Dec 2, 2014 Abandoned
Array ( [id] => 10268351 [patent_doc_number] => 20150153347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'LUNG CANCER DIAGNOSTIC ASSAY' [patent_app_type] => utility [patent_app_number] => 14/552534 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20830 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552534 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/552534
LUNG CANCER DIAGNOSTIC ASSAY Nov 24, 2014 Abandoned
Array ( [id] => 11310197 [patent_doc_number] => 20160346307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'ANTICANCER ADJUVANT COMPOSITION CONTAINING RIP3 EXPRESSION PROMOTER AS ACTIVE INGREDIENT, METHOD FOR SCREENING FOR ANTICANCER ADJUVANT ENHANCING SENSITIVITY OF ANTICANCER DRUG BY PROMOTING RIP3 EXPRESSION, AND METHOD FOR MONITORING SENSITIVITY OF ANTICANCER DRUG' [patent_app_type] => utility [patent_app_number] => 15/116591 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6396 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116591 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/116591
Anticancer adjuvant composition containing RIP3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting RIP3 expression, and method for monitoring sensitivity of anticancer drug Nov 24, 2014 Issued
Array ( [id] => 15247033 [patent_doc_number] => 10509034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-17 [patent_title] => Bladder carcinoma biomarkers [patent_app_type] => utility [patent_app_number] => 15/034585 [patent_app_country] => US [patent_app_date] => 2014-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 14 [patent_no_of_words] => 14449 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034585 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/034585
Bladder carcinoma biomarkers Nov 4, 2014 Issued
Array ( [id] => 11074275 [patent_doc_number] => 20160271239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor' [patent_app_type] => utility [patent_app_number] => 15/034496 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18756 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034496 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/034496
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor Oct 30, 2014 Abandoned
Array ( [id] => 10381964 [patent_doc_number] => 20150266971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/529138 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 46103 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14529138 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/529138
MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE Oct 29, 2014 Abandoned
Array ( [id] => 11874713 [patent_doc_number] => 09746480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Human myeloid derived suppressor cell cancer markers' [patent_app_type] => utility [patent_app_number] => 14/520158 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 18901 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14520158 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/520158
Human myeloid derived suppressor cell cancer markers Oct 20, 2014 Issued
Array ( [id] => 14029571 [patent_doc_number] => 10226518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Ubiquitinylated proteins [patent_app_type] => utility [patent_app_number] => 14/512322 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 5695 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512322 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/512322
Ubiquitinylated proteins Oct 9, 2014 Issued
Array ( [id] => 11102173 [patent_doc_number] => 20160299143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'BREAST CANCER DIAGNOSTIC METHOD AND MEANS' [patent_app_type] => utility [patent_app_number] => 15/026951 [patent_app_country] => US [patent_app_date] => 2014-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14912 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026951 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/026951
BREAST CANCER DIAGNOSTIC METHOD AND MEANS Sep 30, 2014 Abandoned
Menu